Principles of Prescribing - Benzodiazepines

Learning Objectives

  • General Principles:
    • Review pharmacokinetic (pk) terminology.
    • Understand how pk properties impact clinical drug applications.
  • Benzodiazepines:
    • Know the proposed mechanism of action.
    • Identify beneficial and non-beneficial user groups.
    • Recognize common side effects.
    • Understand their adjunctive role in anxiety therapy.

Molecular Target: GABAA Receptors

  • GABAA:
    • Ligand-gated ion channel that allows chloride ions into neurons upon GABA binding.
    • Results in hyperpolarization, preventing action potential firing.

Benzodiazepine Effects on GABAA Receptors

  • Mechanism of Action:
    • Benzodiazepines are positive allosteric modulators (PAMs), binding to a different site than GABA.
    • This enhances the inhibitory effects of GABA, leading to greater hyperpolarization and action potential inhibition.
  • CNS Effects:
    • Benzodiazepines reduce central nervous system (CNS) activity, producing anxiolytic, muscle relaxant, antiepileptic, and sedative effects.

Key Terms: Addiction, Tolerance, Dependence, Withdrawal

  • Addiction:
    • Psychological dependence with a focus on substance acquisition/use.
  • Tolerance:
    • Increased doses needed for the same drug effect.
  • Dependence:
    • Physiological adaptation from repeated drug use.
  • Withdrawal Symptoms:
    • Adverse effects from abrupt cessation of drug intake.

Cautions Regarding Use

  • General Risks:
    • Risk of addiction, misuse, and withdrawal syndrome; guidelines include limited duration and lowest effective dose.
  • Withdrawal Symptoms:
    • Can include insomnia, anxiety, appetite loss, tremor, perspiration, tinnitus, and perceptual disturbances.

Contraindications & Common Side Effects

  • Contraindications:
    • Mild anxiety, chronic use, monotherapy.
    • Not suitable for depression, bereavement, substance abuse history, PTSD, or individuals with respiratory issues.
  • Common Side Effects:
    • Sedation, fatigue, dizziness, ataxia, confusion, and paradoxical effects such as hyper-excitability.

Pharmacokinetics (PK) Terminology

  • Key Terms:
    • Half-life: Time taken for serum concentration to reduce by half.
    • Steady State: Maintained plasma concentration after consistent administration.
    • Tmax: Time taken to reach peak serum concentrations.

Benzodiazepines: Examples with Pharmacokinetics

  • Chlordiazepoxide:
    • Route: Oral, Tmax: 1.5-4 hours, Half-life: 5-30 hours, Use: Alcohol withdrawal, anxiety.
  • Diazepam:
    • Route: Oral, Tmax: 1-1.5 hours, Half-life: 20-100 hours, Use: Anxiety, muscle relaxation, sedation.
  • Clonazepam:
    • Route: Oral, Tmax: 1-4 hours, Half-life: 18-50 hours, Use: Anxiety disorders, epilepsy.
  • Lorazepam:
    • Route: IM, Tmax: 1-1.5 hours, Half-life: 12-16 hours, Use: Acute agitation/anxiety episodes.

Clinical Effects of Benzodiazepines

  • GABAA Receptor Subtypes:
    • α1 Subunit:
    • Effects: Sedation, anti-epileptic, amnesic (found in cortex, thalamus, cerebellum).
    • α2 Subunit:
    • Effects: Anxiolytic, muscle relaxant (found in limbic system, motor neurons).

Serotonin Therapies in Anxiety Disorders

  • SSRIs:
    • Effective in managing various anxiety disorders by targeting serotonergic pathways.
  • Buspirone:
    • Used for GAD; functions as a 5-HT1A partial agonist; delayed therapeutic action but promotes neuroplasticity for fear extinction.

Case Study: Fatimah

  • Background:
    • 28-year-old with panic disorder following childbirth complications.
  • Symptoms Observed:
    • Episodes of extreme stress and impending dread that led to recurrent panic attacks.

Management of Case Study

  • Treatment Administered:
    • Benzodiazepine: Clonazepam 2 mg twice daily (tapered after 2 weeks).
    • SSRI: Fluoxetine 10 mg (titrated to 40 mg).
  • Outcomes:
    • Immediate relief within three days; anxiety management classes pursued after stabilization.

Key Conclusions

  • Benzodiazepines vary in pharmacodynamics and pharmacokinetics; their application is influenced by these differences.
  • Risks of abuse and dependence necessitate cautious use; SSRIs are more suitable for long-term anxiety management.

Resources

  • For Healthcare Professionals:
    • BNF for controlled drug guidelines, SSRIs.
    • Literature: Pharmacology texts, journal articles.
  • Patient Resources:
    • eMC for patient information leaflets on benzodiazepines and anxiety treatments.